课题基金 / 基金详情

A NOVEL THERAPY FOR GLUCOSE INTOLERANCE IN HIV DISEASE

A NOVEL THERAPY FOR GLUCOSE INTOLERANCE IN HIV DISEASE
治疗艾滋病毒葡萄糖不耐受的新疗法
批准号:
7607885
负责人:
MARIE C GELATO
金额:
$12.17万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-03-23 至 2007-11-30

项目摘要

项目成果

MARIE C GELATO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This research is to investigate the nutritional supplement chromium picolinate. A large number of people use chromium picolinate from health food stores to improve function of the hormone insulin. We are testing how effective this supplement is and we are also monitoring its safety. SInce multidrug treatment for HIV can cause insensitivity or resisitance to insulin, we are studying HIV positive individulas with documented insulin resistance. In patients with diabetes, chromium has been shown to increase sensitivity to the hormone insulin. We would like to know if chromium is also effective in treating resistance associated with HIV disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MECHANISMS OF SUBCUTANEOUS FAT LOSS IN AGING AND HIV DISEASE
CLINICAL TRIAL: A NOVEL THERAPY FOR GLUCOSE INTOLERANCE IN HIV DISEASE
CELLULAR MECHANISMS FOR SARCOPENIA IN THE ELDERLY
PPAR MEDICATED GENE EXPRESSION IN HIV PATIENTS
海外基金